Capital Fund Management (CFM)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-82,933
Closed -$4.41M 2521
2025
Q2
$4.41M Buy
+82,933
New +$4.21M 0.01% 1223
2024
Q3
Sell
-64,496
Closed -$3.64M 2025
2024
Q2
$2.72M Buy
+64,496
New +$3.55M 0.01% 1242
2019
Q4
Sell
-35,737
Closed -$3.23M 1878
2019
Q3
$3.23M Sell
35,737
-32,031
-47% -$3.65M 0.03% 623
2019
Q2
$8M Buy
67,768
+23,661
+54% +$2.38M 0.07% 368
2019
Q1
$3.82M Buy
44,107
+37,295
+547% +$3.17M 0.03% 588
2018
Q4
$430K Sell
6,812
-40,900
-86% -$2.81M ﹤0.01% 1448
2018
Q3
$3.77M Sell
47,712
-12,170
-20% -$794K 0.02% 880
2018
Q2
$3.58M Sell
59,882
-191,251
-76% -$10.3M 0.02% 863
2018
Q1
$10.1M Buy
+251,133
New +$12.3M 0.06% 452
2016
Q4
Sell
-129,423
Closed -$2.09M 1712
2016
Q3
$2.4M Buy
+129,423
New +$2.28M 0.02% 699
2015
Q4
Sell
-337,974
Closed -$6.08M 1605
2015
Q3
$6.08M Buy
337,974
+314,055
+1,313% +$7.21M 0.07% 355
2015
Q2
$711K Buy
+23,919
New +$601K 0.01% 942

Other funds holding EXAS

Capital Fund Management (CFM)'s EXAS Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 82,933 shares — an estimated $4.41M sold.

Capital Fund Management (CFM) first reported a position in EXAS in Q2 2015 and held it in 12 quarters. The position peaked at $10.1M in Q1 2018. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 82,933 Exact Sciences shares in Q3 2025, an estimated $4.41M.
  • Capital Fund Management (CFM) first reported a position in Exact Sciences in Q2 2015 and held it in 12 quarters.
  • Capital Fund Management (CFM)'s Exact Sciences position peaked at $10.1M in Q1 2018.
  • 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.